Ganglioside GI

Ganglioside GI is a lipid of Sphingolipids (SP) class. Ganglioside gi is associated with abnormalities such as HIV Infections, Amyotrophic Lateral Sclerosis, Neuritis, Motor, Motor Neuron Disease and athymia. The involved functions are known as Gene Expression, antigen binding, Protective Agents, Binding (Molecular Function) and response to hormone stimulus. Ganglioside gi often locates in Membrane, Body tissue, Mucous Membrane, integral to membrane and Virion. The associated genes with Ganglioside GI are Fusion Protein, synthetic peptide, CTBS gene, IL2 gene and CD4 gene. The related lipids are Sphingolipids, sialogangliosides, Membrane Lipids, ganglioside, Gx and polysialoganglioside. The related experimental models are Knock-out, Disease model, Experimental Autoimmune Encephalomyelitis, Rodent Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Ganglioside GI, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ganglioside GI?

Ganglioside GI is suspected in Neuropathy, Neuritis, Motor, Cholera, Gangliosidosis GM1, Virus Diseases, Neuritis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Ganglioside GI

MeSH term MeSH ID Detail
Cell Transformation, Neoplastic D002471 126 associated lipids
Brain Ischemia D002545 89 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Gaucher Disease D005776 13 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with Ganglioside GI

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ganglioside GI?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ganglioside GI?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ganglioside GI?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ganglioside GI?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ganglioside GI?

Knock-out

Knock-out are used in the study 'GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis.' (Tessitore A et al., 2004) and Knock-out are used in the study 'GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model.' (Hadaczek P et al., 2015).

Transgenic Model

Transgenic Model are used in the study 'Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice.' (Di Pardo A et al., 2012).

Disease model

Disease model are used in the study 'Amyloid-β induced toxicity involves ganglioside expression and is sensitive to GM1 neuroprotective action.' (Kreutz F et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Ganglioside GI

Download all related citations
Per page 10 20 50 100 | Total 3081
Authors Title Published Journal PubMed Link
Godshall CJ et al. Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages. 2003 Shock pmid:12578123
Apostolski S and Latov N Clinical syndromes associated with anti-GM1 antibodies. 1993 Semin Neurol pmid:8272597
Nagale SV and Bosch EP Multifocal motor neuropathy with conduction block: current issues in diagnosis and treatment. 2003 Semin Neurol pmid:14722828
Aykutlu E et al. No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: a pilot study. 2005 Seizure pmid:15927491
Umesaki Y et al. Interactions between epithelial cells and bacteria, normal and pathogenic. 1997 Science pmid:9139662
Read DH et al. Neuronal-visceral GM1 gangliosidosis in a dog with beta-galactosidase deficiency. 1976 Science pmid:824730
Schneider JS et al. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment. 1992 Science pmid:1350379
Guan JL Cell biology. Integrins, rafts, Rac, and Rho. 2004 Science pmid:14764856
Palazzo AF et al. Localized stabilization of microtubules by integrin- and FAK-facilitated Rho signaling. 2004 Science pmid:14764879
del Pozo MA et al. Integrins regulate Rac targeting by internalization of membrane domains. 2004 Science pmid:14764880
Freed EO Virology. Rafting with Ebola. 2002 Science pmid:11951027
Spiegel S et al. Direct evidence that endogenous GM1 ganglioside can mediate thymocyte proliferation. 1985 Science pmid:2999979
Hwang J et al. Nanoscale complexity of phospholipid monolayers investigated by near-field scanning optical microscopy. 1995 Science pmid:7570018
Ribi HO et al. Three-dimensional structure of cholera toxin penetrating a lipid membrane. 1988 Science pmid:3344432
Alroy J et al. Neurovisceral and skeletal GM1-gangliosidosis in dogs with beta-galactosidase deficiency. 1985 Science pmid:3925555
Sabel BA et al. GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage. 1984 Science pmid:6740316
Richards JM et al. Rectal insemination modifies immune responses in rabbits. 1984 Science pmid:6608789
Viola A et al. T lymphocyte costimulation mediated by reorganization of membrane microdomains. 1999 Science pmid:9924026
Ryu YS et al. Continuity of Monolayer-Bilayer Junctions for Localization of Lipid Raft Microdomains in Model Membranes. 2016 Sci Rep pmid:27230411
Eich C et al. Changes in membrane sphingolipid composition modulate dynamics and adhesion of integrin nanoclusters. 2016 Sci Rep pmid:26869100
Lardone RD et al. Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome. 2016 Sci Rep pmid:26818965
Takahashi R and Yuki N Streptococcal IdeS: therapeutic potential for Guillain-Barré syndrome. 2015 Sci Rep pmid:26194472
Hata R et al. Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice. 2015 Sci Rep pmid:25765541
Hamorsky KT et al. N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential. 2015 Sci Rep pmid:25614217
Evangelisti E et al. Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases. 2016 Sci Rep pmid:27619987
Hao C et al. Interaction between ganglioside G(M1) and diosgenin in langmuir monolayers at the air/water interface. Scanning pmid:23553978
Bromander AK et al. Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. 1993 Scand. J. Immunol. pmid:8469928
Eren E et al. Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferation. 2006 Scand. J. Immunol. pmid:16398696
Palmieri G et al. TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cells. 1992 Scand. J. Immunol. pmid:1535986
Müller C et al. Characterization of autoantibodies to natural killer cells in HIV-infected patients. 1996 Scand. J. Immunol. pmid:8633218
Asea A et al. Histaminergic regulation of natural killer cell-mediated clearance of tumour cells in mice. 1996 Scand. J. Immunol. pmid:8560202
Allan JE and Doherty PC Natural killer cells contribute to inflammation but do not appear to be essential for the induction of clinical lymphocytic choriomeningitis. 1986 Scand. J. Immunol. pmid:3489282
Ghayur T et al. Induction, specificity and elimination of asialo-GM1+ graft-versus-host effector cells of donor origin. 1991 Scand. J. Immunol. pmid:1833814
MacDonald GC and Gartner JG Natural killer (NK) cell activity in mice with acute graft-versus-host reactions: characterization of a Thy-1+ NK-like cell with a broadened spectrum of lytic activity in the spleen and lymph nodes. 1991 Scand. J. Immunol. pmid:1709518
Sihvola M Lymphokine-activated killer cells in mouse bone marrow chimaeras. The relationship to natural killer cells and to alloreactive cytotoxic T cells. 1985 Scand. J. Immunol. pmid:2867599
Somasundaram R et al. Limitations of the severe combined immunodeficiency (SCID) mouse model for study of human B-cell responses. 1995 Scand. J. Immunol. pmid:7899826
Wilson AD et al. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. 1990 Scand. J. Immunol. pmid:2333468
Hurme M et al. Highly increased natural killer cell number and lytic activity in the murine peripheral blood and lungs after interferon induction in vivo. 1984 Scand. J. Immunol. pmid:6209790
Beaumont TJ et al. Comparative analysis of cell surface markers on murine NK cells and CTL target-effector conjugates. 1982 Scand. J. Immunol. pmid:6127796
Owman T et al. Radiographic skeletal changes in juvenile GM1-gangliosidosis. 1980 Rofo pmid:6450132
Ogawa G et al. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody]. 2009 Rinsho Shinkeigaku pmid:19827599
Koike Y et al. [A case of progressive encephalomyelitis with rigidity and myoclonus associated with anti-GAD, anti-glycine receptor and anti-GM1 antibodies]. 2015 Rinsho Shinkeigaku pmid:25746075
Arai M and Kusunoki S [A case of multifocal motor neuropathy with IgM lambda anti-GM1 antibody and IgM kappa paraprotein reacting exclusively with GM2]. Rinsho Shinkeigaku pmid:19348179
Lievens I et al. [Multifocal motor neuropathy: a retrospective study of sensory nerve conduction velocities in long-term follow-up of 21 patients]. 2009 Rev. Neurol. (Paris) pmid:19118851
Lefèvre C et al. [Acute motor axon neuropathy, subtype of Guillain-Barre syndrome]. 2002 Rev. Neurol. (Paris) pmid:12072835
Attarian S et al. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies]. 1997 Rev. Neurol. (Paris) pmid:9296136
Coste S et al. [Acute polyradiculoneuropathy after Chlamydia pneumoniae infection]. 2002 Rev. Neurol. (Paris) pmid:11976599
Le Forestier N and Bouche P [Motor conduction block]. 2000 Rev. Neurol. (Paris) pmid:10891806
Azulay JP et al. [Lower motor neuron disease and signs of dysimmunity]. 2000 Rev. Neurol. (Paris) pmid:10795014
Badía Picazo MC et al. [Hyperreflexia in a patient with Guillain Barre syndrome]. Rev Neurol pmid:15098195